Last Updated:
Shares of Gland Pharma slipped 7 per cent to Rs 1,735.05 on the National Stock Exchange (NSE) in Tuesday’s intraday commerce after over 5 per cent of complete fairness of the drug firm modified palms on the counter. The inventory had hit a 52-week excessive of Rs 2,195.75 on February 7, 2024.
Besides, a mixed 12.09 million shares had modified palms on the NSE and BSE until the time of writing of this report. In comparability, the Nifty 50 was up 0.32 per cent at 22,738.
The supply worth for the transaction was anticipated to be at a reduction of round 7 from the earlier shut, with the transaction aimed to earn the 2 entities a complete of Rs 1,400 crore.
Nicomac Machinery held a 1.2 per cent stake in Gland Pharma, whereas RP Advisory Services owned a 3.74 per cent stake in Gland Pharma, the corporate’s December quarter shareholding information present.
Penmetsa will proceed to have round a p.c steadiness stake within the agency.
